ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,077, issued on May 12, was assigned to CHUGAI SEIYAKU K.K. (Tokyo).
"CXCR3 ligand" was invented by Yohei Yamamoto (Shizuoka, Japan), Mika Sakurai (Shizuoka, Japan) and Kenta Haraya (Shizuoka, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to CXCR3 ligands having resistance to DPPIV and having CXCR3-expressing cell migration-inducing activity. The present disclosure specifically relates to N-terminal amino acid modifications and N-terminal amino acid sequences important for resistance to DPPIV and CXCR3-expressing cell migration-inducing activity."
The patent was filed on Dec. 4, 2019, under Application No. 17/299...